Economic evaluation Keetharuth, A.D., Gould, R.L., McDermott, C.J., et al. (2024). Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life. Eur J Neurol, 31, e16317. DOI: 10.1111/ene.16317 (not counted separately f
Overview
This resource presents an economic evaluation of acceptance and commitment therapy for individuals with motor neuron disease, focusing on cost-effectiveness and health-related quality of life outcomes. It is a peer-reviewed academic paper published in the European Journal of Neurology.
- ID
2bc090cd601440b7- Source org
- ACBS
- Author
- Anju Keetharuth (University of Sheffield), Rebecca L. Gould (University College London), Christopher McDermott (University of Sheffield), Benjamin J. Thompson (University of Sheffield), Charlotte Rawlinson (University College London), Mike Bradburn (University of Sheffield), Matthew Bursnall (University of Sheffield), Pavithra Kumar (University of Sheffield), Emily Turton (University of Sheffield), Paul Tappenden (University of Sheffield), David White (University of Sheffield), Robert Howard (University College London), Marc Serfaty (The Priory Hospital), Lance M. McCracken (Uppsala University), Christopher D. Graham (University of Strathclyde), Ammar Al‐Chalabi (King's College London), Laura H. Goldstein (King's College London), Vanessa Lawrence (King's College London), Cindy Cooper (University of Sheffield), Tracey Young (University of Sheffield)
- Published
- 2024-04-25
- OA status
- gold
- DOI
- 10.1111/ene.16317
- PMID
- Not recorded
- PMCID
- Not recorded
- Citations
- 2
Tags
Verification
- identityok via crossref · score 0.95 · checked_at unknown
- legitimacykeep via unknown · score 0.95 · checked_at unknown
- linkblocked via http-check · 2026-07-28T05:51:39.503185+00:00
Cite this entry
BibTeX
@article{allodium:2bc090cd601440b7,
title = {Economic evaluation Keetharuth, A.D., Gould, R.L., McDermott, C.J., et al. (2024). Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life. Eur J Neurol, 31, e16317. DOI: 10.1111/ene.16317 (not counted separately f},
author = {Anju Keetharuth and Rebecca L. Gould and Christopher McDermott and Benjamin J. Thompson and Charlotte Rawlinson and Mike Bradburn and Matthew Bursnall and Pavithra Kumar and Emily Turton and Paul Tappenden and David White and Robert Howard and Marc Serfaty and Lance M. McCracken and Christopher D. Graham and Ammar Al‐Chalabi and Laura H. Goldstein and Vanessa Lawrence and Cindy Cooper and Tracey Young},
year = {2024},
journal = {ACBS},
doi = {10.1111/ene.16317},
url = {https://doi.org/10.1111/ene.16317}
}RIS
TY - JOUR TI - Economic evaluation Keetharuth, A.D., Gould, R.L., McDermott, C.J., et al. (2024). Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life. Eur J Neurol, 31, e16317. DOI: 10.1111/ene.16317 (not counted separately f AU - Keetharuth, Anju AU - Gould, Rebecca L. AU - McDermott, Christopher AU - Thompson, Benjamin J. AU - Rawlinson, Charlotte AU - Bradburn, Mike AU - Bursnall, Matthew AU - Kumar, Pavithra AU - Turton, Emily AU - Tappenden, Paul AU - White, David AU - Howard, Robert AU - Serfaty, Marc AU - McCracken, Lance M. AU - Graham, Christopher D. AU - Al‐Chalabi, Ammar AU - Goldstein, Laura H. AU - Lawrence, Vanessa AU - Cooper, Cindy AU - Young, Tracey PY - 2024 PB - ACBS DO - 10.1111/ene.16317 UR - https://doi.org/10.1111/ene.16317 ER -
APA
Keetharuth, A., Gould, R. L., McDermott, C., Thompson, B. J., Rawlinson, C., Bradburn, M., Bursnall, M., Kumar, P., Turton, E., Tappenden, P., White, D., Howard, R., Serfaty, M., McCracken, L. M., Graham, C. D., Al‐Chalabi, A., Goldstein, L. H., Lawrence, V., Cooper, C., & Young, T. (2024). Economic evaluation Keetharuth, A.D., Gould, R.L., McDermott, C.J., et al. (2024). Cost-effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health-related quality of life. Eur J Neurol, 31, e16317. DOI: 10.1111/ene.16317 (not counted separately f. ACBS. https://doi.org/10.1111/ene.16317
Related entries
- Quality of life in people with motor neuron disease; ACT + usual care vs. usual care. N=191. Gould, R. L., McDermott, C. J., Thompson, B. J., Rawlinson, C. V., Bursnall, M., Bradburn, M., et al. (2024). Acceptance and Commitment Therapy plus usual care for improving quality of life in people with mo
- Extended Research Article Gould, R.L., Thompson, B.J., Rawlinson, C.V., Bursnall, M., Bradburn, M., Keetharuth, A.D., et al. (2025). Acceptance and Commitment Therapy for people living with motor neuron disease: the COMMEND feasibility study and randomised controlled trial. Health Technology Assessm
- Are acceptance and mindfulness‐based interventions ‘value for money’? Evidence from a systematic literature review
- Economic Impact of Third-Wave Cognitive Behavioral Therapies: A Systematic Review and Quality Assessment of Economic Evaluations in Randomized Controlled Trials
- Effectiveness of acceptance and commitment therapy for improving quality of life and mood in individuals with multiple sclerosis: A systematic review and meta-analysis
- Economic evaluation Shields, G., Rowlandson, A., Davies, L., Leadbitter, K., & Green, J. (2024). EE735 A New Post-Diagnostic Psycho-Education and Acceptance and Commitment Therapy Program for Caregivers of Children Recently Diagnosed With Autism Spectrum Disorder (REACH-ASD): A Trial-Based Cost-Effe
- The effectiveness of cognitive behavioral therapy in patients with motor neuron disease: A systematic review
- A scoping review to identify process and outcome measures used in acceptance and commitment therapy research, with adults with acquired neurological conditions
- Cost-Utility of Group Acceptance and Commitment Therapy for Fibromyalgia Versus Recommended Drugs: An Economic Analysis Alongside a 6-Month Randomized Controlled Trial Conducted in Spain (EFFIGACT Study)
- Economic evaluation Osstyn, S., Rauwenhoff, J., Handels, R., de Vugt, M. E., Evers, S., van Mastrigt, G. A. P. G., & van Heugten, C. M. (2025). Trial-based economic evaluation of the BrainACT study: acceptance and commitment therapy for anxiety and/or depressive symptoms after acquired brain injury.